• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov11
Editas Medicine released FY2025 9 Months Earnings on November 10, 2025 (EST) with actual revenue of USD 15.78 M and EPS of USD -1.8255
04:00
Editas Medicine released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 7.543 M (forecast USD 4.945 M), actual EPS USD -0.2787 (forecast USD -0.3121)
04:00
Oct6
Editas Medicine to Report CRISPR Gene Editing Drug Data at ESGCT Conference
13:00
Aug13
Editas Medicine released FY2025 Semi-Annual earnings on August 12 (EST), actual revenue USD 8.236 M, actual EPS USD -1.5443
03:00
Editas Medicine released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 3.578 M (forecast USD 1.805 M), actual EPS USD -0.6306 (forecast USD -0.3836)
03:00
Jul3
Editas Medicine Showcases Progress in Gene Editing for Beta Thalassemia and Sickle Cell Disease
13:20

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 7.543 M, Net Income -25.12 M, EPS -0.2787

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.578 M, Net Income -53.24 M, EPS -0.6306

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 4.658 M, Net Income -76.09 M, EPS -0.9161

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SMX
382.800
+171.49%
+241.800
GURE
10.505
+121.62%
+5.630
TGL
11.200
+65.73%
+4.442
WHLR
5.351
+65.17%
+2.110
IRBT
4.520
+49.17%
+1.488
TDIC
0.4153
+47.90%
+0.135
TWNP
1.594
+39.82%
+0.460
PRAX
264.230
+39.09%
+74.260
TORO
5.610
+35.83%
+1.480
GFR.RT
1.110
+30.59%
+0.260
View More